Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) POCT enables quick and accurate diagnostic testing with ... Read More
-
Global Precision Cardiometabolic Growth Opportunities
... cost burden has become significant and is anticipated to rise further. Existing drug therapies for these conditions are focused on a one-size-fits-all approach, and there is a lack of patient-centricity and variability in disease management. ... Read More
-
Insulin Manufacturing in the US - Industry Market Research Report
... for the treatment of type 1 and type 2 diabetes mellitus. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year ... Read More
-
Patient Engagement Solutions Market based on by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) & Regional Outlook– Global Forecast up to 2030
... 2030 In order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To ... Read More
-
Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... Key Companies, 2023 Update provides comprehensive information about the Infusion Pumps pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Infusion ... Read More
-
Remote Patient Monitoring Market Forecasts to 2030 – Global Analysis By Type (Monitoring Devices and Software & Services), Condition (Diabetes, Congestive Heart Failure, Blood Pressure, Chronic Obstructive Pulmonary Disease, Mental Health and Other Conditions), End User and By Geography
... User and By Geography According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $2.6 billion in 2023 and is expected to reach $8.6 billion by 2030 growing at a CAGR of ... Read More
-
Xylitol – A Global Market Overview
... associated with the incidence of type-2 diabetes, with reduction in weight being high on the recommendations list of preventing and managing diabetes. In this context, low-calorie sweeteners offer an ideal substitute to added sugars, with ... Read More
-
Trypsin-EDTA Solution for Cell Dissociation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (0.25% Solution, 0.05% Solution), By Application (Insulin Manufacturing, Vaccines Manufacturing, Cell Culture, Other) By Region and Competition
... Competition Global Trypsin-EDTA Solution for Cell Dissociation Market has valued at USD 1.01 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 5.90% through 2028. The ... Read More
-
Remote Patient Monitoring Market / RPM Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro), End user (Providers, Hospitals, Clinics, Home care, Patients, Payers) & Region - Global Forecast to 2028
... 2028 The global remote patient monitoring market is projected to reach USD 41.7 billion by 2028 from USD 14.0 billion in 2023, at a CAGR of 20.1% between 2023 and 2028. The increasing elderly population, ... Read More
-
Alginate Dressings Market - Global Alginate Dressings Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Type Coverage, By Form Coverage, By Application Coverage, By End User Coverage, By Geographic Coverage and By Company)
... and By Company) The global alginate dressings market, valued at approximately US$0.9 billion in 2022, is poised for robust growth, with forecasts indicating a significant expansion to reach US$1.24 billion by the end of 2030. ... Read More
-
Diabetic Socks Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 284.7 Million by 2028, exhibiting a growth rate (CAGR) of 5.3% during 2022-2028. Most diabetic patients suffer from neuropathy and peripheral vascular diseases. These diseases narrow the blood vessels and increase the chances of developing ... Read More
-
Biopharmaceutical Market Size, Share, and Analysis, By Product Type (Purified Proteins, Recombinant Growth Factors, Recombinant Proteins, Recombinant Hormone, Synthetic Immunomodulatory, Monoclonal Antibodies, Vaccines, Other), By Service (Custom Testing / Customer Proprietary Testing, Laboratory Testing, Compendial, and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious Diseases, Hormonal Disorders, Neurological Diseases, Cardiovascular Diseases, and Other) and Regional Forecasts, 2022-2032
... and Multi Compendial Laboratory Testing), By Raw Material Type (Active Pharmaceutical Ingredients (API), Formulation Excipients, Compendial Methods (USP/ EP/ JP) Based Vendor Qualification Program Support), By Application (Autoimmune Disorders, Metabolic Disorders, Oncology, Inflammatory and Infectious ... Read More
-
Global Insulinoma Treatment Market - 2023-2030
... period 2023-2030. Insulinomas are rare pancreatic endocrine tumors that can be benign or malignant. Only 10% of insulinomas are malignant. The main symptom is hypoglycemia, i.e., a decrease in blood sugar levels due to the ... Read More
-
Pharma Contract Sales Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Global Players Consolidating CRO and CSO Operations to ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Russia Continuous Blood Glucose Monitoring Systems Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2030
... study of the Russia market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Russia market. Also, factors that are driving and restraining the continuous blood ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
Asia Pacific Clinical Trials Market Forecast to 2028 – Regional Analysis – by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Asia Pacific clinical trials market is expected to grow from US$ 8,670.68 million in 2022 to US$ 13,114.04 million by 2028. It is estimated to grow ... Read More
-
Global Hemoglobin A1C Testing Market, Forecast to 2028
... advances and the increasing adoption of point-of-care testing (POCT). Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results. By streamlining data collection, this ... Read More
-
Canada Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition (Standard Nutrition, Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, Others (Proteins, Lipids among Others))), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Others (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases and Others)), By End User (Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities)
... (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases ... Read More
-
Enteral Feeding Devices Market, By Product Type ( Feeding Tubes( Nasogastric Tube with ENFit Connector, Orogastric Tube, Nasoenteric Tube, Oroenteric Tube, Gastrostomy Tube (G Tube) with ENFit Connector, Jejunostomy Tubes), By Age Group (ediatric, Adults), By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... By Application (Diabetes, Oncology, Gastrointestinal Diseases, Hypermetabolism, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Enteral Feeding Devices Market, By ... Read More
-
Pen Needles Market by Type (Standard Pen & Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormone), and Mode of Purchase, End User, Unmet Needs, Key Stakeholders, Buying Criteria - Global Forecast to 2028
... Criteria - Global Forecast to 2028 The global pen needles market size is projected to reach USD 2.5 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 9.1% during the forecast ... Read More
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, ... Read More
Research Assistance
